CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology service.
Daniel Mark FountainRory J PiperMichael T C PoonGeorgios SolomouPaul M BrennanYasir A ChowdhuryFrancesca ColomboTarek ElmoslemanyFrederick G EwbankPaul L GrundyMd T HasanMolly HillingPeter J HutchinsonKonstantina KarabatsouAngelos G KoliasNathan J McSorleyChristopher P MillwardIsaac PhangPuneet PlahaStephen J PriceOla RominiyiWilliam SageSyed ShumonInes L SilvaStuart J SmithSurash SurashSimon ThomsonJun Y LauColin WattsMichael D Jenkinsonnull nullPublished in: Neuro-oncology advances (2021)
Disruption to neuro-oncology services in the UK caused by the COVID-19 pandemic was most marked in the first month, affecting all diagnoses. Patients considered for chemotherapy were most affected. In those recommended surgical treatment this was successfully completed. Longer-term outcome data will evaluate oncological treatments received by these patients and overall survival.